These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 6141240

  • 1. The purported dopamine agonist DPI inhibits [3H]noradrenaline release from rat cortical slices but not [3H]dopamine and [14C]acetylcholine release from rat striatal slices in-vitro.
    Van Oene JC, Sminia P, Mulder AH, Horn AS.
    J Pharm Pharmacol; 1983 Dec; 35(12):786-92. PubMed ID: 6141240
    [Abstract] [Full Text] [Related]

  • 2. Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an alpha 2-adrenergic mechanism.
    van Oene JC, Houwing HA, Horn AS.
    Eur J Pharmacol; 1982 Jun 16; 81(1):75-87. PubMed ID: 6126370
    [Abstract] [Full Text] [Related]

  • 3. Is TL-99 a selective presynaptic dopamine receptor agonist?
    Horn AS, De Vries J, Dijkstra D, Mulder AH.
    Eur J Pharmacol; 1982 Sep 10; 83(1-2):35-45. PubMed ID: 7128699
    [Abstract] [Full Text] [Related]

  • 4. Interaction between the inhibitory action of acetylcholine and the alpha-adrenoceptor autoinhibitory feedback system on release of [3H]-noradrenaline from rat atria and rabbit ear artery.
    Loiacono RE, Rand MJ, Story DF.
    Br J Pharmacol; 1985 Mar 10; 84(3):697-705. PubMed ID: 2859064
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Agonistic actions of DPI (2-(3,4-dihydroxyphenylimino)-imidazolidine) on alpha-adrenoceptors and dopamine receptors.
    Woodman OL, Medgett IC, Lang WJ, Rand MJ.
    Eur J Pharmacol; 1981 Oct 15; 75(1):11-9. PubMed ID: 6119208
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 3,4-disubstituted phenyliminoimidazolidines as potential prodrugs of the purported dopamine agonist 3,4-dihydroxyphenylimino-2-imidazolidine (DPI).
    Houwing HA, van Oene JC, Horn AS.
    Pharm Weekbl Sci; 1983 Aug 26; 5(4):177-81. PubMed ID: 6622213
    [Abstract] [Full Text] [Related]

  • 10. Neurochemical investigations in vitro with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in preparations of rat brain.
    Markstein R, Lahaye D.
    Eur J Pharmacol; 1984 Nov 13; 106(2):301-11. PubMed ID: 6335691
    [Abstract] [Full Text] [Related]

  • 11. Dopamine release is enhanced while acetylcholine release is inhibited by nimodipine (Bay e 9736).
    Nordström O, Braesch-Andersen S, Bartfai T.
    Acta Physiol Scand; 1986 Jan 13; 126(1):115-9. PubMed ID: 3953299
    [Abstract] [Full Text] [Related]

  • 12. Effect of a sulfonium analog of dopamine on the depolarization-induced release of [3H]acetylcholine from mouse striatal slices.
    Turowski B, Szkrybalo M, Anderson K, Miller D, Uretsky N.
    Biochem Pharmacol; 1984 Aug 01; 33(15):2371-6. PubMed ID: 6466358
    [Abstract] [Full Text] [Related]

  • 13. Effect of permanently charged and uncharged dopaminergic agonists on the potassium-induced release of [3H]acetylcholine from striatal slices.
    Sabol B, Boldry R, Farooqui T, Chang YA, Miller D, Uretsky N.
    Biochem Pharmacol; 1987 May 15; 36(10):1679-85. PubMed ID: 3109428
    [Abstract] [Full Text] [Related]

  • 14. Role of 5-HT3 receptors in basal and K(+)-evoked dopamine release from rat olfactory tubercle and striatal slices.
    Zazpe A, Artaiz I, Del Río J.
    Br J Pharmacol; 1994 Nov 15; 113(3):968-72. PubMed ID: 7858893
    [Abstract] [Full Text] [Related]

  • 15. Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slices.
    Langeveld CH, Schepens E, Stoof JC, Bast A, Drukarch B.
    Free Radic Biol Med; 1995 Aug 15; 19(2):209-17. PubMed ID: 7649492
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.
    Sacaan AI, Dunlop JL, Lloyd GK.
    J Pharmacol Exp Ther; 1995 Jul 15; 274(1):224-30. PubMed ID: 7542334
    [Abstract] [Full Text] [Related]

  • 17. Agonist and antagonist effects of 3-PPP enantiomers on functional dopamine autoreceptors and postsynaptic dopamine receptors in vitro.
    Mulder AH, Draper R, Sminia P, Schoffelmeer AN, Stoof JC.
    Eur J Pharmacol; 1985 Jan 08; 107(3):291-7. PubMed ID: 3979429
    [Abstract] [Full Text] [Related]

  • 18. Increased dopamine release from rat striatal slices by inhibitors of GABA-aminotransferase.
    Stoof JC, Mulder AH.
    Eur J Pharmacol; 1977 Nov 15; 46(2):177-80. PubMed ID: 590329
    [Abstract] [Full Text] [Related]

  • 19. Ontogenetic development of high potassium- and acetylcholine-induced release of dopamine from striatal slices of the rat.
    Nomura Y, Yotsumoto I, Segawa T.
    Brain Res; 1981 Apr 15; 227(2):171-7. PubMed ID: 7225887
    [Abstract] [Full Text] [Related]

  • 20. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
    Cadogan AK, Alexander SP, Boyd EA, Kendall DA.
    J Neurochem; 1997 Sep 15; 69(3):1131-7. PubMed ID: 9282935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.